Terms: = Lung cancer AND ERCC4, XPF, 2072, ENSG00000175595, Q92889 AND Prognosis
4 results:
1. Unveiling Novel ERCC1-xpf Complex Inhibitors: Bridging the Gap from In Silico Exploration to Experimental Design.
Manguinhas R; Serra PA; Soares RB; Rosell R; Gil N; Oliveira NG; Guedes RC
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279246
[TBL] [Abstract] [Full Text] [Related]
2. Gene network Analysis Defines a Subgroup of Small Cell lung cancer patients With Short Survival.
Cucchiara F; Petrini I; Passaro A; Attili I; Crucitta S; Pardini E; de Marinis F; Danesi R; Del Re M
Clin Lung Cancer; 2022 Sep; 23(6):510-521. PubMed ID: 35739016
[TBL] [Abstract] [Full Text] [Related]
3. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
Cierna Z; Miskovska V; Roska J; Jurkovicova D; Pulzova LB; Sestakova Z; Hurbanova L; Machalekova K; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Kajo K; Babal P; Mardiak J; Ward TA; Mego M; Chovanec M
BMC Cancer; 2020 Jan; 20(1):17. PubMed ID: 31906898
[TBL] [Abstract] [Full Text] [Related]
4. Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer.
Lamba JK; Fridley BL; Ghosh TM; Yu Q; Mehta G; Gupta P
Pharmacogenomics; 2014; 15(12):1565-74. PubMed ID: 25340731
[TBL] [Abstract] [Full Text] [Related]
